- Open Access
Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
Arthritis Research & Therapy volume 19, Article number: 11 (2017)
- The original article was published in Arthritis Research & Therapy 2016 18:294
Unfortunately, after publication of this article , it was noticed that the name of Gianfranco Ferraccioli was incorrectly spelled as Gianfranco Ferraciolli. The corrected author list can be seen above and the original article has been updated to correct this error.
Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraccioli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X. Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Res Ther. 2016;18:294. http://doi.org/10.1186/s13075-016-1190-z.
The online version of the original article can be found under doi:10.1186/s13075-016-1190-z.
About this article
Cite this article
Sellam, J., Rivière, E., Courties, A. et al. Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Res Ther 19, 11 (2017). https://doi.org/10.1186/s13075-017-1221-4